Ethinyl estradiol/levonorgestrel

DRUG3 trials

Sponsors

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), AbbVie, AstraZeneca

Conditions

DyslipidaemiaHIV InfectionsHematologic Malignancies

Phase 1

A Study to Assess the Effect of Venetoclax on Ethinyl Estradiol and Levonorgestrel in Female Participants With Different Hematological Malignancies

RecruitingNCT03557619

AbbVieHematologic Malignancies

Start: 2019-07-30End: 2026-03-21Target: 12Updated: 2024-08-29

An Open-label Study in Healthy Participants to Evaluate AZD0780 as an Object or Precipitant of CYP3A4-mediated Drug-drug Interactions

CompletedNCT06671405

AstraZenecaDyslipidaemia

Start: 2024-09-25End: 2025-02-17Updated: 2025-04-27

Unknown Phase

Hormonal Birth Control and the Risk of Acquiring HIV

CompletedNCT00006324

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)HIV Infections

Start: 1999-12-31End: 2002-12-31Target: 6360Updated: 2008-08-07